104 related articles for article (PubMed ID: 38948214)
1. Identification and serological responses to a novel
Marzano-Miranda A; Pereira Cardoso-Oliveira G; Carla de Oliveira I; Carvalho Mourão L; Reis Cussat L; Gomes Fraga V; Delfin Chávez Olórtegui C; Jesus Fernandes Fontes C; Castanheira Bartholomeu D; Braga EM
PeerJ; 2024; 12():e17632. PubMed ID: 38948214
[TBL] [Abstract][Full Text] [Related]
2. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.
Riccio EK; Totino PR; Pratt-Riccio LR; Ennes-Vidal V; Soares IS; Rodrigues MM; de Souza JM; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2013 Sep; 12():326. PubMed ID: 24041406
[TBL] [Abstract][Full Text] [Related]
4. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
[TBL] [Abstract][Full Text] [Related]
5. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
7. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.
Lima-Junior JC; Jiang J; Rodrigues-da-Silva RN; Banic DM; Tran TM; Ribeiro RY; Meyer VS; De-Simone SG; Santos F; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2011 Feb; 29(9):1801-11. PubMed ID: 21215342
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.
Sepúlveda N; Morais CG; Mourão LC; Freire MF; Fontes CJ; Lacerda MV; Drakeley CJ; Braga ÉM
Malar J; 2016 Nov; 15(1):559. PubMed ID: 27852258
[TBL] [Abstract][Full Text] [Related]
9. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
10. Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil.
Ladeia-Andrade S; Ferreira MU; Scopel KK; Braga EM; Bastos Mda S; Wunderlich G; Coura JR
Mem Inst Oswaldo Cruz; 2007 Dec; 102(8):943-51. PubMed ID: 18209933
[TBL] [Abstract][Full Text] [Related]
11. Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax.
del Portillo HA; Levitus G; Camargo LM; Ferreira MU; Mertens F
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():77-84. PubMed ID: 1343729
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
Sachdeva S; Ahmad G; Malhotra P; Mukherjee P; Chauhan VS
Infect Immun; 2004 Oct; 72(10):5775-82. PubMed ID: 15385477
[TBL] [Abstract][Full Text] [Related]
13. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti.
Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA
Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796
[TBL] [Abstract][Full Text] [Related]
14. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
Bitencourt AR; Vicentin EC; Jimenez MC; Ricci R; Leite JA; Costa FT; Ferreira LC; Russell B; Nosten F; Rénia L; Galinski MR; Barnwell JW; Rodrigues MM; Soares IS
PLoS One; 2013; 8(2):e56061. PubMed ID: 23457498
[TBL] [Abstract][Full Text] [Related]
15. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
[TBL] [Abstract][Full Text] [Related]
16. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.
Storti-Melo LM; Souza-Neiras WC; Cassiano GC; Taveira LC; Cordeiro AJ; Couto VS; Póvoa MM; Cunha MG; Echeverry DM; Rossit AR; Arévalo-Herrera M; Herrera S; Machado RL
Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):58-63. PubMed ID: 21292879
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS; Oliveira SG; Souza JM; Rodrigues MM
Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
20. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
